1016 All-Oral 12-Week Combination Treatment With Daclatasvir (DCV) and Sofosbuvir (SOF) in Treatment-Experienced Patients Infected With HCV Genotype (GT) 3: A Subanalysis of the Ally-3 Phase 3 Study
Gespeichert in:
| Autor*in: |
Nelson, David [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|
| Erschienen: |
2015 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Ubiquitin protease Ubp8 is necessary for - Leo, Manuela ELSEVIER, 2018, official publication of the American Gastroenterological Association, Stanford, Calif |
|---|---|
| Übergeordnetes Werk: |
volume:148 ; year:2015 ; number:4 ; pages:0 |
| Links: |
|---|
| DOI / URN: |
10.1016/S0016-5085(15)33422-3 |
|---|
| Katalog-ID: |
ELV01344123X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV01344123X | ||
| 003 | DE-627 | ||
| 005 | 20230623105217.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180602s2015 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1016/S0016-5085(15)33422-3 |2 doi | |
| 028 | 5 | 2 | |a GBVA2015021000015.pica |
| 035 | |a (DE-627)ELV01344123X | ||
| 035 | |a (ELSEVIER)S0016-5085(15)33422-3 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 570 |q VZ |
| 084 | |a BIODIV |q DE-30 |2 fid | ||
| 084 | |a 35.70 |2 bkl | ||
| 084 | |a 42.12 |2 bkl | ||
| 084 | |a 42.15 |2 bkl | ||
| 100 | 1 | |a Nelson, David |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a 1016 All-Oral 12-Week Combination Treatment With Daclatasvir (DCV) and Sofosbuvir (SOF) in Treatment-Experienced Patients Infected With HCV Genotype (GT) 3: A Subanalysis of the Ally-3 Phase 3 Study |
| 264 | 1 | |c 2015 | |
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 700 | 1 | |a Bernstein, David |4 oth | |
| 700 | 1 | |a Freilich, Bradley |4 oth | |
| 700 | 1 | |a Lawitz, Eric |4 oth | |
| 700 | 1 | |a Hawkins, Trevor |4 oth | |
| 700 | 1 | |a Pockros, Paul J. |4 oth | |
| 700 | 1 | |a Thuluvath, Paul J. |4 oth | |
| 700 | 1 | |a Younes, Ziad H. |4 oth | |
| 700 | 1 | |a Bennett, Michael |4 oth | |
| 700 | 1 | |a Ghalib, Reem |4 oth | |
| 700 | 1 | |a Ruane, Peter J. |4 oth | |
| 700 | 1 | |a Tong, Myron J. |4 oth | |
| 700 | 1 | |a Bhore, Rafia |4 oth | |
| 700 | 1 | |a Yin, Philip D. |4 oth | |
| 700 | 1 | |a Noviello, Stephanie |4 oth | |
| 700 | 1 | |a Rana, Khurram |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n HighWire Press |a Leo, Manuela ELSEVIER |t Ubiquitin protease Ubp8 is necessary for |d 2018 |d official publication of the American Gastroenterological Association |g Stanford, Calif |w (DE-627)ELV000307017 |
| 773 | 1 | 8 | |g volume:148 |g year:2015 |g number:4 |g pages:0 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/S0016-5085(15)33422-3 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a FID-BIODIV | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 35.70 |j Biochemie: Allgemeines |q VZ |
| 936 | b | k | |a 42.12 |j Biophysik |q VZ |
| 936 | b | k | |a 42.15 |j Zellbiologie |q VZ |
| 951 | |a AR | ||
| 952 | |d 148 |j 2015 |e 4 |h 0 |y 148.2015, 4, S-1003- | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
d n dn |
|---|---|
| matchkey_str |
nelsondavidbernsteindavidfreilichbradley:2015----:06loa1wecmiainramnwtdcaavrcadoobvroitetetxeineptetifcewthveo |
| hierarchy_sort_str |
2015 |
| bklnumber |
35.70 42.12 42.15 |
| publishDate |
2015 |
| allfields |
10.1016/S0016-5085(15)33422-3 doi GBVA2015021000015.pica (DE-627)ELV01344123X (ELSEVIER)S0016-5085(15)33422-3 DE-627 ger DE-627 rakwb 610 610 DE-600 570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl 42.15 bkl Nelson, David verfasserin aut 1016 All-Oral 12-Week Combination Treatment With Daclatasvir (DCV) and Sofosbuvir (SOF) in Treatment-Experienced Patients Infected With HCV Genotype (GT) 3: A Subanalysis of the Ally-3 Phase 3 Study 2015 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Bernstein, David oth Freilich, Bradley oth Lawitz, Eric oth Hawkins, Trevor oth Pockros, Paul J. oth Thuluvath, Paul J. oth Younes, Ziad H. oth Bennett, Michael oth Ghalib, Reem oth Ruane, Peter J. oth Tong, Myron J. oth Bhore, Rafia oth Yin, Philip D. oth Noviello, Stephanie oth Rana, Khurram oth Enthalten in HighWire Press Leo, Manuela ELSEVIER Ubiquitin protease Ubp8 is necessary for 2018 official publication of the American Gastroenterological Association Stanford, Calif (DE-627)ELV000307017 volume:148 year:2015 number:4 pages:0 https://doi.org/10.1016/S0016-5085(15)33422-3 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA 35.70 Biochemie: Allgemeines VZ 42.12 Biophysik VZ 42.15 Zellbiologie VZ AR 148 2015 4 0 148.2015, 4, S-1003- 045F 610 |
| spelling |
10.1016/S0016-5085(15)33422-3 doi GBVA2015021000015.pica (DE-627)ELV01344123X (ELSEVIER)S0016-5085(15)33422-3 DE-627 ger DE-627 rakwb 610 610 DE-600 570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl 42.15 bkl Nelson, David verfasserin aut 1016 All-Oral 12-Week Combination Treatment With Daclatasvir (DCV) and Sofosbuvir (SOF) in Treatment-Experienced Patients Infected With HCV Genotype (GT) 3: A Subanalysis of the Ally-3 Phase 3 Study 2015 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Bernstein, David oth Freilich, Bradley oth Lawitz, Eric oth Hawkins, Trevor oth Pockros, Paul J. oth Thuluvath, Paul J. oth Younes, Ziad H. oth Bennett, Michael oth Ghalib, Reem oth Ruane, Peter J. oth Tong, Myron J. oth Bhore, Rafia oth Yin, Philip D. oth Noviello, Stephanie oth Rana, Khurram oth Enthalten in HighWire Press Leo, Manuela ELSEVIER Ubiquitin protease Ubp8 is necessary for 2018 official publication of the American Gastroenterological Association Stanford, Calif (DE-627)ELV000307017 volume:148 year:2015 number:4 pages:0 https://doi.org/10.1016/S0016-5085(15)33422-3 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA 35.70 Biochemie: Allgemeines VZ 42.12 Biophysik VZ 42.15 Zellbiologie VZ AR 148 2015 4 0 148.2015, 4, S-1003- 045F 610 |
| allfields_unstemmed |
10.1016/S0016-5085(15)33422-3 doi GBVA2015021000015.pica (DE-627)ELV01344123X (ELSEVIER)S0016-5085(15)33422-3 DE-627 ger DE-627 rakwb 610 610 DE-600 570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl 42.15 bkl Nelson, David verfasserin aut 1016 All-Oral 12-Week Combination Treatment With Daclatasvir (DCV) and Sofosbuvir (SOF) in Treatment-Experienced Patients Infected With HCV Genotype (GT) 3: A Subanalysis of the Ally-3 Phase 3 Study 2015 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Bernstein, David oth Freilich, Bradley oth Lawitz, Eric oth Hawkins, Trevor oth Pockros, Paul J. oth Thuluvath, Paul J. oth Younes, Ziad H. oth Bennett, Michael oth Ghalib, Reem oth Ruane, Peter J. oth Tong, Myron J. oth Bhore, Rafia oth Yin, Philip D. oth Noviello, Stephanie oth Rana, Khurram oth Enthalten in HighWire Press Leo, Manuela ELSEVIER Ubiquitin protease Ubp8 is necessary for 2018 official publication of the American Gastroenterological Association Stanford, Calif (DE-627)ELV000307017 volume:148 year:2015 number:4 pages:0 https://doi.org/10.1016/S0016-5085(15)33422-3 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA 35.70 Biochemie: Allgemeines VZ 42.12 Biophysik VZ 42.15 Zellbiologie VZ AR 148 2015 4 0 148.2015, 4, S-1003- 045F 610 |
| allfieldsGer |
10.1016/S0016-5085(15)33422-3 doi GBVA2015021000015.pica (DE-627)ELV01344123X (ELSEVIER)S0016-5085(15)33422-3 DE-627 ger DE-627 rakwb 610 610 DE-600 570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl 42.15 bkl Nelson, David verfasserin aut 1016 All-Oral 12-Week Combination Treatment With Daclatasvir (DCV) and Sofosbuvir (SOF) in Treatment-Experienced Patients Infected With HCV Genotype (GT) 3: A Subanalysis of the Ally-3 Phase 3 Study 2015 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Bernstein, David oth Freilich, Bradley oth Lawitz, Eric oth Hawkins, Trevor oth Pockros, Paul J. oth Thuluvath, Paul J. oth Younes, Ziad H. oth Bennett, Michael oth Ghalib, Reem oth Ruane, Peter J. oth Tong, Myron J. oth Bhore, Rafia oth Yin, Philip D. oth Noviello, Stephanie oth Rana, Khurram oth Enthalten in HighWire Press Leo, Manuela ELSEVIER Ubiquitin protease Ubp8 is necessary for 2018 official publication of the American Gastroenterological Association Stanford, Calif (DE-627)ELV000307017 volume:148 year:2015 number:4 pages:0 https://doi.org/10.1016/S0016-5085(15)33422-3 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA 35.70 Biochemie: Allgemeines VZ 42.12 Biophysik VZ 42.15 Zellbiologie VZ AR 148 2015 4 0 148.2015, 4, S-1003- 045F 610 |
| allfieldsSound |
10.1016/S0016-5085(15)33422-3 doi GBVA2015021000015.pica (DE-627)ELV01344123X (ELSEVIER)S0016-5085(15)33422-3 DE-627 ger DE-627 rakwb 610 610 DE-600 570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl 42.15 bkl Nelson, David verfasserin aut 1016 All-Oral 12-Week Combination Treatment With Daclatasvir (DCV) and Sofosbuvir (SOF) in Treatment-Experienced Patients Infected With HCV Genotype (GT) 3: A Subanalysis of the Ally-3 Phase 3 Study 2015 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Bernstein, David oth Freilich, Bradley oth Lawitz, Eric oth Hawkins, Trevor oth Pockros, Paul J. oth Thuluvath, Paul J. oth Younes, Ziad H. oth Bennett, Michael oth Ghalib, Reem oth Ruane, Peter J. oth Tong, Myron J. oth Bhore, Rafia oth Yin, Philip D. oth Noviello, Stephanie oth Rana, Khurram oth Enthalten in HighWire Press Leo, Manuela ELSEVIER Ubiquitin protease Ubp8 is necessary for 2018 official publication of the American Gastroenterological Association Stanford, Calif (DE-627)ELV000307017 volume:148 year:2015 number:4 pages:0 https://doi.org/10.1016/S0016-5085(15)33422-3 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA 35.70 Biochemie: Allgemeines VZ 42.12 Biophysik VZ 42.15 Zellbiologie VZ AR 148 2015 4 0 148.2015, 4, S-1003- 045F 610 |
| source |
Enthalten in Ubiquitin protease Ubp8 is necessary for Stanford, Calif volume:148 year:2015 number:4 pages:0 |
| sourceStr |
Enthalten in Ubiquitin protease Ubp8 is necessary for Stanford, Calif volume:148 year:2015 number:4 pages:0 |
| format_phy_str_mv |
Article |
| bklname |
Biochemie: Allgemeines Biophysik Zellbiologie |
| institution |
findex.gbv.de |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Ubiquitin protease Ubp8 is necessary for |
| authorswithroles_txt_mv |
Nelson, David @@aut@@ Bernstein, David @@oth@@ Freilich, Bradley @@oth@@ Lawitz, Eric @@oth@@ Hawkins, Trevor @@oth@@ Pockros, Paul J. @@oth@@ Thuluvath, Paul J. @@oth@@ Younes, Ziad H. @@oth@@ Bennett, Michael @@oth@@ Ghalib, Reem @@oth@@ Ruane, Peter J. @@oth@@ Tong, Myron J. @@oth@@ Bhore, Rafia @@oth@@ Yin, Philip D. @@oth@@ Noviello, Stephanie @@oth@@ Rana, Khurram @@oth@@ |
| publishDateDaySort_date |
2015-01-01T00:00:00Z |
| hierarchy_top_id |
ELV000307017 |
| dewey-sort |
3610 |
| id |
ELV01344123X |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV01344123X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623105217.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2015 xx |||||o 00| ||und c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/S0016-5085(15)33422-3</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2015021000015.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV01344123X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0016-5085(15)33422-3</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">BIODIV</subfield><subfield code="q">DE-30</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.70</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">42.12</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">42.15</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Nelson, David</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">1016 All-Oral 12-Week Combination Treatment With Daclatasvir (DCV) and Sofosbuvir (SOF) in Treatment-Experienced Patients Infected With HCV Genotype (GT) 3: A Subanalysis of the Ally-3 Phase 3 Study</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bernstein, David</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Freilich, Bradley</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lawitz, Eric</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hawkins, Trevor</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pockros, Paul J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Thuluvath, Paul J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Younes, Ziad H.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bennett, Michael</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ghalib, Reem</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ruane, Peter J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tong, Myron J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bhore, Rafia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yin, Philip D.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Noviello, Stephanie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rana, Khurram</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">HighWire Press</subfield><subfield code="a">Leo, Manuela ELSEVIER</subfield><subfield code="t">Ubiquitin protease Ubp8 is necessary for</subfield><subfield code="d">2018</subfield><subfield code="d">official publication of the American Gastroenterological Association</subfield><subfield code="g">Stanford, Calif</subfield><subfield code="w">(DE-627)ELV000307017</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:148</subfield><subfield code="g">year:2015</subfield><subfield code="g">number:4</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/S0016-5085(15)33422-3</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-BIODIV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.70</subfield><subfield code="j">Biochemie: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">42.12</subfield><subfield code="j">Biophysik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">42.15</subfield><subfield code="j">Zellbiologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">148</subfield><subfield code="j">2015</subfield><subfield code="e">4</subfield><subfield code="h">0</subfield><subfield code="y">148.2015, 4, S-1003-</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Nelson, David |
| spellingShingle |
Nelson, David ddc 610 ddc 570 fid BIODIV bkl 35.70 bkl 42.12 bkl 42.15 1016 All-Oral 12-Week Combination Treatment With Daclatasvir (DCV) and Sofosbuvir (SOF) in Treatment-Experienced Patients Infected With HCV Genotype (GT) 3: A Subanalysis of the Ally-3 Phase 3 Study |
| authorStr |
Nelson, David |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV000307017 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 570 - Life sciences; biology |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl 42.15 bkl 1016 All-Oral 12-Week Combination Treatment With Daclatasvir (DCV) and Sofosbuvir (SOF) in Treatment-Experienced Patients Infected With HCV Genotype (GT) 3: A Subanalysis of the Ally-3 Phase 3 Study |
| topic |
ddc 610 ddc 570 fid BIODIV bkl 35.70 bkl 42.12 bkl 42.15 |
| topic_unstemmed |
ddc 610 ddc 570 fid BIODIV bkl 35.70 bkl 42.12 bkl 42.15 |
| topic_browse |
ddc 610 ddc 570 fid BIODIV bkl 35.70 bkl 42.12 bkl 42.15 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
d b db b f bf e l el t h th p j p pj pjp p j t pj pjt z h y zh zhy m b mb r g rg p j r pj pjr m j t mj mjt r b rb p d y pd pdy s n sn k r kr |
| hierarchy_parent_title |
Ubiquitin protease Ubp8 is necessary for |
| hierarchy_parent_id |
ELV000307017 |
| dewey-tens |
610 - Medicine & health 570 - Life sciences; biology |
| hierarchy_top_title |
Ubiquitin protease Ubp8 is necessary for |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV000307017 |
| title |
1016 All-Oral 12-Week Combination Treatment With Daclatasvir (DCV) and Sofosbuvir (SOF) in Treatment-Experienced Patients Infected With HCV Genotype (GT) 3: A Subanalysis of the Ally-3 Phase 3 Study |
| ctrlnum |
(DE-627)ELV01344123X (ELSEVIER)S0016-5085(15)33422-3 |
| title_full |
1016 All-Oral 12-Week Combination Treatment With Daclatasvir (DCV) and Sofosbuvir (SOF) in Treatment-Experienced Patients Infected With HCV Genotype (GT) 3: A Subanalysis of the Ally-3 Phase 3 Study |
| author_sort |
Nelson, David |
| journal |
Ubiquitin protease Ubp8 is necessary for |
| journalStr |
Ubiquitin protease Ubp8 is necessary for |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology 500 - Science |
| recordtype |
marc |
| publishDateSort |
2015 |
| contenttype_str_mv |
zzz |
| container_start_page |
0 |
| author_browse |
Nelson, David |
| container_volume |
148 |
| class |
610 610 DE-600 570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl 42.15 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Nelson, David |
| doi_str_mv |
10.1016/S0016-5085(15)33422-3 |
| dewey-full |
610 570 |
| title_sort |
1016 all-oral 12-week combination treatment with daclatasvir (dcv) and sofosbuvir (sof) in treatment-experienced patients infected with hcv genotype (gt) 3: a subanalysis of the ally-3 phase 3 study |
| title_auth |
1016 All-Oral 12-Week Combination Treatment With Daclatasvir (DCV) and Sofosbuvir (SOF) in Treatment-Experienced Patients Infected With HCV Genotype (GT) 3: A Subanalysis of the Ally-3 Phase 3 Study |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA |
| container_issue |
4 |
| title_short |
1016 All-Oral 12-Week Combination Treatment With Daclatasvir (DCV) and Sofosbuvir (SOF) in Treatment-Experienced Patients Infected With HCV Genotype (GT) 3: A Subanalysis of the Ally-3 Phase 3 Study |
| url |
https://doi.org/10.1016/S0016-5085(15)33422-3 |
| remote_bool |
true |
| author2 |
Bernstein, David Freilich, Bradley Lawitz, Eric Hawkins, Trevor Pockros, Paul J. Thuluvath, Paul J. Younes, Ziad H. Bennett, Michael Ghalib, Reem Ruane, Peter J. Tong, Myron J. Bhore, Rafia Yin, Philip D. Noviello, Stephanie Rana, Khurram |
| author2Str |
Bernstein, David Freilich, Bradley Lawitz, Eric Hawkins, Trevor Pockros, Paul J. Thuluvath, Paul J. Younes, Ziad H. Bennett, Michael Ghalib, Reem Ruane, Peter J. Tong, Myron J. Bhore, Rafia Yin, Philip D. Noviello, Stephanie Rana, Khurram |
| ppnlink |
ELV000307017 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/S0016-5085(15)33422-3 |
| up_date |
2024-07-06T18:54:31.095Z |
| _version_ |
1803856978741559296 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV01344123X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623105217.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2015 xx |||||o 00| ||und c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/S0016-5085(15)33422-3</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2015021000015.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV01344123X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0016-5085(15)33422-3</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">BIODIV</subfield><subfield code="q">DE-30</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.70</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">42.12</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">42.15</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Nelson, David</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">1016 All-Oral 12-Week Combination Treatment With Daclatasvir (DCV) and Sofosbuvir (SOF) in Treatment-Experienced Patients Infected With HCV Genotype (GT) 3: A Subanalysis of the Ally-3 Phase 3 Study</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bernstein, David</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Freilich, Bradley</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lawitz, Eric</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hawkins, Trevor</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pockros, Paul J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Thuluvath, Paul J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Younes, Ziad H.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bennett, Michael</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ghalib, Reem</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ruane, Peter J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tong, Myron J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bhore, Rafia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yin, Philip D.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Noviello, Stephanie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rana, Khurram</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">HighWire Press</subfield><subfield code="a">Leo, Manuela ELSEVIER</subfield><subfield code="t">Ubiquitin protease Ubp8 is necessary for</subfield><subfield code="d">2018</subfield><subfield code="d">official publication of the American Gastroenterological Association</subfield><subfield code="g">Stanford, Calif</subfield><subfield code="w">(DE-627)ELV000307017</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:148</subfield><subfield code="g">year:2015</subfield><subfield code="g">number:4</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/S0016-5085(15)33422-3</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-BIODIV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.70</subfield><subfield code="j">Biochemie: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">42.12</subfield><subfield code="j">Biophysik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">42.15</subfield><subfield code="j">Zellbiologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">148</subfield><subfield code="j">2015</subfield><subfield code="e">4</subfield><subfield code="h">0</subfield><subfield code="y">148.2015, 4, S-1003-</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.400528 |